ArticleScience advances2024

The HDAC6 inhibitor AVS100 (SS208) induces a pro-inflammatory tumor microenvironment and potentiates immunotherapy.

Damian Kovalovsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.